pharmaceutical investing Opiant Pharmaceuticals, Inc. Reports First Quarter 2018 Financial Results and Provides Corporate Update
pharmaceutical investing Daré Bioscience announces funding award to further the development of Ovaprene
pharmaceutical investing Opiant Pharmaceuticals Awarded Grant of Approximately $7.4 Million from the National Institutes of Health for Development of OPNT003
pharmaceutical investing Inovio and The Wistar Institute Receive More Than $4.6 Million in R&D Funding
MediciNova Announces MN-166 (ibudilast) Demonstrated a 26% Reduction in Confirmed Disability Progression
1911 Gold Closes C$13.2 Million "Bought Deal" Life Offering Including Increased Investment by Eric Sprott
